Acid Reducer
NDC Package 51660-352-69
Package Information
Acid Reducer is ranitidine is known as an H2 blocker. Marketed by Ohm Laboratories Inc., this product is identified by NDC 51660-352 and is authorized under FDA application ANDA201745.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51660 - Ohm Laboratories Inc.
- 51660-352 - Acid Reducer
- 51660-352-69 - 1 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 51660-352 - Acid Reducer
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51660-352). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51660-352-69 identifies a specific commercial package of 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Acid Reducer, labeled by Ohm Laboratories Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ohm Laboratories Inc. on July 10, 2012. The current certification is valid through September 11, 2019.
What are the primary indications for this medication?
Ranitidine is known as an H2 blocker. It works by reducing the amount of acid in your stomach. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). This drug has been withdrawn from the US market due to problems with safety. A possible cancer-causing impurity has been found in some ranitidine products.
How is this Ohm Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51660035269. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.